search
Back to results

Comparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on Obesity

Primary Purpose

Obesity, Diabetes Mellitus

Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Behavioral and Drug
Behavioral
Behavioral and Drug
Behavioral
Sponsored by
US Department of Veterans Affairs
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring Intense Exercise/Moderate Calorie Restriction, Topiramate-Phentermine

Eligibility Criteria

20 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 20-70 years
  • Competent to give informed consent
  • Obesity (BMI>40) or BMI>35 kg/m2 with associated co-morbidities
  • Diabetes Mellitus Type II

Exclusion Criteria:

  • History of coronary artery disease, myocardial infarction, coronary angioplasty or bypass surgery
  • Prior non-cardiac illness with an estimated life expectancy <4 years
  • Unable to give informed consent
  • Women who are pregnant or lactating
  • Prior bariatric surgery or receiving anti-obesity drugs

Sites / Locations

  • Captain James A. Lovell Federal Health Care Center, North Chicago, IL

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

IE-MCR

TP-CBT

CBT

Arm Description

Intense Exercise/Moderate Calorie Restriction

Topiramate-Phentermine plus cognitive behavioral therapy

cognitive behavioral therapy

Outcomes

Primary Outcome Measures

Compare the rate of change in fat mass in intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavior therapy
compare the change in extracellular/total body water, body fat/lean mass and metabolically active adipose tissue in response to IE-MCR vs. TP-CBT.

Secondary Outcome Measures

Compare the rate of atherosclerotic burden in intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavior therapy
Compare the change in carotid intima media thickness, coronary artery distensibility index and plaque volume in response to IE-MCR,TP or CBT.
Compare the change in neuropsychiatric status in response to intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavioral therapy
compare the change in cognition, anxiety, depression and vitality in response to IE-MCR, TP and CBT.
Comparison the rate of and atherosclerotic burden in intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavior therapy
Compare the change in carotid intima media thickness, coronary artery distensibility index and plaque volume in response to IE-MCR,TP or CBT.
Compare the change in quality-of-life in response to intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavioral therapy
Compare the change in satisfaction, well-Being and quality of life in response to IE-MCR, TP and CBT

Full Information

First Posted
August 28, 2013
Last Updated
January 14, 2014
Sponsor
US Department of Veterans Affairs
search

1. Study Identification

Unique Protocol Identification Number
NCT01970566
Brief Title
Comparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on Obesity
Official Title
Effect of Intense-Exercise/Moderate-Calorie vs Topiramate-Phentermine on Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
January 2014
Overall Recruitment Status
Withdrawn
Why Stopped
The project was not announced to the field and it was not funded.
Study Start Date
November 2013 (undefined)
Primary Completion Date
August 2015 (Anticipated)
Study Completion Date
November 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
US Department of Veterans Affairs

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Obesity is a prevalent disorder and linked with inflammation, insulin resistance, dyslipidemia, obstructive sleep apnea, atherosclerosis, and associated with significant morbidity and mortality. This randomized clinical trial will compare the effectiveness of Intense Exercise/Moderate Calorie Restriction (IE-MCR), Topiramate-Phentermine (TP) and cognitive behavioral therapy (CBT) on obesity and atherosclerosis in individuals with morbidly obesity. This randomized clinical trial will compare: 1) the change in fat mass and atherosclerosis, 2) the change in psychological and quality-of-life as well as economic burden in response to IE-MCR, TP and CBT, and 3) conduct exploratory mechanistic biomolecular, genetic and therapeutic analyses to develop intervention-specific individualized intervention models to improve management of morbidly obese individuals.
Detailed Description
Background. Obesity is prevalent disorder; up to 60% of US population that is associated with significant morbidity and mortality through inflammation, insulin resistance, dyslipidemia, obstructive sleep apnea, and atherosclerosis. The economic burden of obesity-related illnesses is substantial, with estimates ranging from 2% to 7% of the total US health care expenditures and billions of dollars in direct and indirect costs to society. This randomized clinical trial will compared the effectiveness of Intense Exercise/Moderate Calorie Restriction (IE-MCR), Topiramate-Phentermine (TP) and cognitive behavioral therapy (CBT) on obesity and atherosclerosis in morbidly obesity individuals (body mass index(BMI)>40 kg/m2 or BMI>35 kg/m2 with associated comorbidities) with diabetes mellitus (DM). Importance/Significance. There is a cumulative increase in the rate of obesity, up to 60% of the US population. This randomized clinical trial will compare: 1) the change in fat mass and atherosclerosis and, 2) the change in psychological status and quality-of-life as well as economic burden in response to IE-MCR, TP and CBT in morbidly obese individuals with DM. Furthermore, 3) exploratory analyses evaluating the different underling adipocyte molecular mechanisms will be conducted. This will investigate the underlying genomic determinants and characterizes the management of obesity by comparing biologic, clinical phenotype, and cost effectiveness of these two interventions. These aims will provide fundamental information to assess the beneficial effects within and across interventions on obesity and atherosclerosis management which will help provide individualized intervention models to improve management of morbidly obese individuals Method. A significant difference in reduction of fat mass, carotid/coronary atherosclerosis, improve in psychological, quality of life and economic burden measures, as well as exploratory mechanism of action across IE-MCR, TP and CBT methods, are hypothesized. Over a 5 year period, 60 morbidly obese individuals with diabetes mellitus aged 18 or older and free of clinical cardiovascular disease will be recruited from the Obesity Clinic of the Greater Los Angeles VA Health Care System, University of California Los Angeles and Captain Lovell Federal Healthcare Center. Eligible subjects will be randomized to either of intense exercise/moderate calorie restriction, Topiramate-Phentermine or cognitive behavioral therapy (20 in each group) and receive these intervention for 12-months. Intense exercise/moderate calorie restriction group will receive lectures on exercise and general dietary measures including calorie counting. They will prepare their own food, with protein:carbohydrate:fat ratio of 30:45:25 and over 70% of their resting daily energy expenditure (RDEE), and completed daily food and exercise journals. They will exercise ~2.5 hours/day, about 1/4 supervised, for a year. Topiramate-Phentermine group will receive full dose of TP (15/92mg) pills daily for a period of 1-year. Furthermore, CBT group as well as IE-MCR and TP will receive weekly cognitive behavior therapy for a year. All subjects will undergo carotid ultrasound; coronary computed tomography angiography, bioelectric impedance spectroscopy, dual-energy X-ray absorptiometry, ambulatory calorimetry, serial home resting metabolic rate serial home (RMR),sleep apnea assessment and abdominal fat pad fine-needle aspiration biopsy (FNAB), as well as measurement of oxidative stress/inflammatory/metabolic biomarkers at baseline and at 1-year follow-up. Quality of life, psychological health and economic burden will be assessed using standardized questionnaires. Participants will complete quarterly trial visits for physical exam, compliance to intervention as well as ascertainment of adverse effects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Diabetes Mellitus
Keywords
Intense Exercise/Moderate Calorie Restriction, Topiramate-Phentermine

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
IE-MCR
Arm Type
Experimental
Arm Description
Intense Exercise/Moderate Calorie Restriction
Arm Title
TP-CBT
Arm Type
Active Comparator
Arm Description
Topiramate-Phentermine plus cognitive behavioral therapy
Arm Title
CBT
Arm Type
Active Comparator
Arm Description
cognitive behavioral therapy
Intervention Type
Other
Intervention Name(s)
Behavioral and Drug
Other Intervention Name(s)
TP-CBT
Intervention Description
Topiramate-Phentermine plus cognitive behavioral therapy
Intervention Type
Other
Intervention Name(s)
Behavioral
Other Intervention Name(s)
IE-MCR
Intervention Description
Intense Exercise/Moderate Calorie Restriction
Intervention Type
Other
Intervention Name(s)
Behavioral and Drug
Other Intervention Name(s)
TP-CBT
Intervention Description
Topiramate-Phentermine plus cognitive behavioral therapy
Intervention Type
Other
Intervention Name(s)
Behavioral
Other Intervention Name(s)
IE-MCR
Intervention Description
Intense Exercise/Moderate Calorie Restriction
Primary Outcome Measure Information:
Title
Compare the rate of change in fat mass in intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavior therapy
Description
compare the change in extracellular/total body water, body fat/lean mass and metabolically active adipose tissue in response to IE-MCR vs. TP-CBT.
Time Frame
12 month and 24 month Follow Ups
Secondary Outcome Measure Information:
Title
Compare the rate of atherosclerotic burden in intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavior therapy
Description
Compare the change in carotid intima media thickness, coronary artery distensibility index and plaque volume in response to IE-MCR,TP or CBT.
Time Frame
12 month and 24 month Follow Ups
Title
Compare the change in neuropsychiatric status in response to intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavioral therapy
Description
compare the change in cognition, anxiety, depression and vitality in response to IE-MCR, TP and CBT.
Time Frame
12 month and 24 month Follow Ups
Title
Comparison the rate of and atherosclerotic burden in intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavior therapy
Description
Compare the change in carotid intima media thickness, coronary artery distensibility index and plaque volume in response to IE-MCR,TP or CBT.
Time Frame
12 month and 24 month Follow Ups
Title
Compare the change in quality-of-life in response to intense exercise/moderate diet restriction, topiramate-phentermine and cognitive behavioral therapy
Description
Compare the change in satisfaction, well-Being and quality of life in response to IE-MCR, TP and CBT
Time Frame
12 month and 24 month Follow Ups

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 20-70 years Competent to give informed consent Obesity (BMI>40) or BMI>35 kg/m2 with associated co-morbidities Diabetes Mellitus Type II Exclusion Criteria: History of coronary artery disease, myocardial infarction, coronary angioplasty or bypass surgery Prior non-cardiac illness with an estimated life expectancy <4 years Unable to give informed consent Women who are pregnant or lactating Prior bariatric surgery or receiving anti-obesity drugs
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Naser Ahmadi, MD MS PhD
Organizational Affiliation
Captain James A. Lovell Federal Health Care Center, North Chicago, IL
Official's Role
Principal Investigator
Facility Information:
Facility Name
Captain James A. Lovell Federal Health Care Center, North Chicago, IL
City
North Chicago
State/Province
Illinois
ZIP/Postal Code
60064
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
20152239
Citation
Ahmadi N, Tsimikas S, Hajsadeghi F, Saeed A, Nabavi V, Bevinal MA, Kadakia J, Flores F, Ebrahimi R, Budoff MJ. Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium. Am J Cardiol. 2010 Feb 15;105(4):459-66. doi: 10.1016/j.amjcard.2009.09.052.
Results Reference
background
PubMed Identifier
21798505
Citation
Ahmadi N, Eshaghian S, Huizenga R, Sosnin K, Ebrahimi R, Siegel R. Effects of intense exercise and moderate caloric restriction on cardiovascular risk factors and inflammation. Am J Med. 2011 Oct;124(10):978-82. doi: 10.1016/j.amjmed.2011.02.032. Epub 2011 Jul 27.
Results Reference
result

Learn more about this trial

Comparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on Obesity

We'll reach out to this number within 24 hrs